Mobile

A multi-center, double-masked study of the safety and efficacy of DuoTrav APS compared to DuoTrav in patients with open-angle glaucoma or ocular hypertension

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-010834-23

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to compare the efficacy and safety of DuoTrav APS to DuoTrav, both dosed once-daily in the morning, in patients with open angle glaucoma or ocular hypertension.

Critère d'inclusion

  • Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension

Liens